Figur8, a Boston, MA-based digital health platform to measure and track body movement as a biomarker, raised $7.5m in seed funding.
The round, which brought total funding raised to date to $7.5m, was led by P5 Health Ventures with participation from E14 Fund, and other individual investors.
Led by CEO Dr. Nan-Wei Gong, Figur8 is a diagnostics platform that captures three-dimensional skeletal movement in conjunction with muscle output to allow clinicians to objectively measure musculoskeletal performance and recovery. The portable system – developed in collaboration between Massachusetts General Hospital (MGH) Sports Science Lab and MIT Media Lab researchers – enables the assessment of the cause, effect and quality of movement to reduce injuries and improve physical performance, recovery and overall health.
In minutes, clinicians can take clients through an assessment to establish a movement health baseline, diagnose movement dysfunction, identify injury risk, optimize exercise routines and monitor progress.
During any movement, Figur8’s patented sensor technology quantifies a combination of micrometer precision signals of muscle activity and joint mobility. From a single movement assessment, over one million unique data points are produced and instantly analyzed by algorithms to generate actionable biomechanical insights for clinicians.
The company is currently working with elite athletes, teams, training facilities and major occupational and physical therapy clinics.